Today’s guest is Daniel Ferrante, AI Leader in R&D and Data Strategy at Deloitte. Together with Emerj CEO and Head of Research Daniel Faggella, they delve into the complex challenges in AI adoption that major pharmaceutical firms encounter with cultural shifts, technological complexities, and the difficulties in monetizing data and aligning teams efficiently. Additionally, the pair explores the future landscape of phenotypical drug discovery, drawing insights from the context of COVID-19. Their focus underscores the critical importance of collecting and analyzing data to yield actionable insights, especially in the healthcare sector and amidst global health crises. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!
How to Identify High-ROI Use Cases for GenAI and Achieve Success Quickly - with Carm Taglienti of Insight
[Beyond GPU] AI Hardware for Computer Vision - with Adam Burns of Intel
[AI Futures] A Debate on What AGI Means for Society and the Species - with Roko Mijic and Roman Yampolskiy
LLMs and Generative AI for Financial Planning and Life Insurance Workflows - with Christian Mitchell of Northwestern Mutual
[Beyond GPU] Solutions for AI Hardware Challenges from Infrastructure to Deployment - with Mark Heaps of Groq
Exploring Use Cases in Foundational Models for Life Sciences, Retail and Manufacturing - with Alberto Rizzoli of V7
Facing Retail Challenges in the Era of Generative AI - with Alan Boehme of H&M
[AI Futures] AI and the Future of Intimacy - with Professor Pani Farvid of the New School
Overcoming Healthcare Challenges with Generative AI and Deep Learning - with Erik Duhaime of Centaur Labs
Operationalizing GenAI Models to Increase Business Value - with Carm Taglienti of Insight
The Impact of AI on Drug Target Discovery and the Personalization of Healthcare - with Leo Barella of Takeda
[Winning Executive Buy-In] Winning Executive Buy-In, From a Vendor’s Perspective - with Zohar Bronfman of Pecan
Telling Fact from Fiction in Launching Enterprise AI and Bespoke LLMs - with Alberto Rizzoli of V7
AI Regulations and Enterprise Legal Exposure - with Anna Gressel of Paul, Weiss
[AI Futures] Intensive vs. Laissez-Faire Approaches to AI Governance - with Robin Hanson of George Mason University
Machine Learning and Large Language Models in Healthcare - with Dr. Arta Bakshandeh of Alignment Health
AI and B2B Customer Journey Signals - with Carlos Quezada of Hewlett Packard Enterprises
AI for Insurance, Insurance for AI - with Edosa Odaro of Tawuniya
Winning Buy-In From Logistics Leaders for AI Projects - with Dorothy Li, CTO of Convoy
Leveling Up Road Safety through AI in Automotive - with Frantz Saintellemy of LeddarTech
Create your
podcast in
minutes
It is Free
Insight Story: Tech Trends Unpacked
Zero-Shot
Fast Forward by Tomorrow Unlocked: Tech past, tech future
The Unbelivable Truth - Series 1 - 26 including specials and pilot
A Prairie Home Companion: News from Lake Wobegon